EB-MF-CAR-NK-01 Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: Mesothelin/FAP Dual-Target CAR-NK Cells

Pipeline

Phase 1/2: 1

Top Sponsors

Beijing Biotech1

Indications

Malignant Pleural Mesotheliomas1
Lung Cancer1
Cancer1

Other1 trial

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.